Healthcare provider profile · identity verified

Margretta Johnson Ameigh, MD

Family Practice · NEW CUMBERLAND, PA · NPI 1760478424

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	586	169
Amlodipine Besylate	Amlodipine Besylate	445	121
Lisinopril	Lisinopril	294	84
Levothyroxine Sodium	Levothyroxine Sodium	280	72
Omeprazole	Omeprazole	242	67
Rosuvastatin Calcium	Rosuvastatin Calcium	196	52
Hydrochlorothiazide	Hydrochlorothiazide	190	51
Metformin Hcl Er	Metformin Hcl	188	50
Pantoprazole Sodium	Pantoprazole Sodium	177	53
Metoprolol Succinate	Metoprolol Succinate	173	52
Losartan Potassium	Losartan Potassium	160	40
Furosemide	Furosemide	152	48
Eliquis	Apixaban	141	31
Gabapentin	Gabapentin	125	35
Simvastatin	Simvastatin	120	34
Albuterol Sulfate Hfa	Albuterol Sulfate	118	38
Alprazolam	Alprazolam	114	21
Metformin Hcl	Metformin Hcl	113	35
Jardiance	Empagliflozin	99	28
Lorazepam	Lorazepam	95	22
Sertraline Hcl	Sertraline Hcl	93	28
Escitalopram Oxalate	Escitalopram Oxalate	90	28
Trazodone Hcl	Trazodone Hcl	88	24
Ozempic	Semaglutide	86	11
Pravastatin Sodium	Pravastatin Sodium	85	24
Tramadol Hcl	Tramadol Hcl	84	20
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	80	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	78	22
Prednisone	Prednisone	78	42
Metoprolol Tartrate	Metoprolol Tartrate	75	20
Allopurinol	Allopurinol	74	19
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	74	11
Potassium Chloride	Potassium Chloride	73	19
Atenolol	Atenolol	72	19
Montelukast Sodium	Montelukast Sodium	68	18
Meloxicam	Meloxicam	67	20
Repaglinide	Repaglinide	61	14
Ibandronate Sodium	Ibandronate Sodium	60	18
Xarelto	Rivaroxaban	54	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	50	13
Fluoxetine Hcl	Fluoxetine Hcl	50	16
Synthroid	Levothyroxine Sodium	49	14
Clopidogrel	Clopidogrel Bisulfate	48	12
Ezetimibe	Ezetimibe	48	15
Glimepiride	Glimepiride	47	13
Bupropion Xl	Bupropion Hcl	44	11
Buspirone Hcl	Buspirone Hcl	44	16
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	44	13
Citalopram Hbr	Citalopram Hydrobromide	41	12
Famotidine	Famotidine	41	12
Myrbetriq	Mirabegron	41	suppressed
Januvia	Sitagliptin Phosphate	39	12
Spironolactone	Spironolactone	39	13
Tamsulosin Hcl	Tamsulosin Hcl	39	16
Repatha Sureclick	Evolocumab	36	suppressed
Carvedilol	Carvedilol	35	12
Lovastatin	Lovastatin	35	suppressed
Topiramate	Topiramate	35	suppressed
Bupropion Hcl Sr	Bupropion Hcl	34	suppressed
Nebivolol Hcl	Nebivolol Hcl	34	11
Valsartan	Valsartan	34	suppressed
Paroxetine Hcl	Paroxetine Hcl	33	suppressed
Azithromycin	Azithromycin	31	24
Duloxetine Hcl	Duloxetine Hcl	31	11
Alendronate Sodium	Alendronate Sodium	30	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	30	suppressed
Clonazepam	Clonazepam	29	suppressed
Diclofenac Sodium	Diclofenac Sodium	29	suppressed
Farxiga	Dapagliflozin Propanediol	29	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	29	12
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	29	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	28	25
Glipizide	Glipizide	28	suppressed
Warfarin Sodium	Warfarin Sodium	28	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	28	suppressed
Valacyclovir	Valacyclovir Hcl	27	suppressed
Meclizine Hcl	Meclizine Hcl	26	suppressed
Telmisartan	Telmisartan	26	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	26	13
Esomeprazole Magnesium	Esomeprazole Magnesium	25	suppressed
Breo Ellipta	Fluticasone/Vilanterol	24	suppressed
Enalapril Maleate	Enalapril Maleate	24	suppressed
Lansoprazole	Lansoprazole	24	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	23	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	23	20
Fluticasone Propionate	Fluticasone Propionate	23	13
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	23	suppressed
Rizatriptan	Rizatriptan Benzoate	23	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	22	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	22	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	22	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	22	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	22	suppressed
Cephalexin	Cephalexin	21	14
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	21	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	21	16
Oxybutynin Chloride Er	Oxybutynin Chloride	21	suppressed
Roflumilast	Roflumilast	21	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	21	18
Bumetanide	Bumetanide	20	suppressed
Celecoxib	Celecoxib	20	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	20	suppressed
Pregabalin	Pregabalin	20	suppressed
Clobetasol Propionate	Clobetasol Propionate	19	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	19	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	18	13
Trimethoprim	Trimethoprim	18	suppressed
Trintellix	Vortioxetine Hydrobromide	18	suppressed
Trulicity	Dulaglutide	18	suppressed
Oxycodone Hcl	Oxycodone Hcl	17	suppressed
Propranolol Hcl Er	Propranolol Hcl	17	suppressed
Aliskiren	Aliskiren Hemifumarate	16	suppressed
Amoxicillin	Amoxicillin	16	12
Belsomra	Suvorexant	16	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	16	suppressed
Clonidine Hcl	Clonidine Hcl	16	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Gemfibrozil	Gemfibrozil	16	suppressed
Naproxen	Naproxen	16	suppressed
Diazepam	Diazepam	15	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	14	11
Fluconazole	Fluconazole	14	suppressed
Jantoven	Warfarin Sodium	14	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	14	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	14	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	13	suppressed
Doxepin Hcl	Doxepin Hcl	13	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Raloxifene Hcl	Raloxifene Hcl	13	suppressed
Ramipril	Ramipril	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Clotrimazole	Clotrimazole	12	suppressed
Digoxin	Digoxin	12	suppressed
Dilt-Xr	Diltiazem Hcl	12	suppressed
Glyxambi	Empagliflozin/Linagliptin	12	suppressed
Liothyronine Sodium	Liothyronine Sodium	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Primidone	Primidone	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Benazepril Hcl	Benazepril Hcl	11	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	11	suppressed
Diltiazem 12hr Er	Diltiazem Hcl	11	suppressed
Entresto	Sacubitril/Valsartan	11	suppressed
Estradiol	Estradiol	11	suppressed
Finasteride	Finasteride	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	11	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Tradjenta	Linagliptin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error